SCHEMBL28804330

SCHEMBL28804330

CN1Cc2cc([N+](=O)[O-])c(Cl)cc2N1

nearest known ligand 0.43

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
AKR1B1 P15121 1/20 0.43
VCAM1 P19320 6/20 0.42
TSHR P16473 1/20 0.38
MAPK1 P28482 1/20 0.38
ALDH1A1 P00352 1/20 0.37
CYP3A4 P08684 1/20 0.37
CA12 O43570 1/20 0.36
CA9 Q16790 1/20 0.36
HTR2A P28223 1/20 0.35
HTR2C P28335 1/20 0.35
HTR2B P41595 1/20 0.35
NPBWR1 P48145 1/20 0.35
MCHR1 Q99705 1/20 0.35
PGK1 P00558 1/20 0.35
HRH4 Q9H3N8 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27150504 0.80 MAPK1 (0.39) TSHRMAPK1ALDH1A1CYP3A4
SCHEMBL654959 0.72 ALDH1A1 (0.45) AKR1B1TSHRALDH1A1
Hydrochloric Acid SCHEMBL10702809 0.70 HTR2A (0.55) VCAM1TSHRMAPK1ALDH1A1CYP3A4
SCHEMBL8646022 0.70 ALDH1A1 (0.62) AKR1B1VCAM1TSHRMAPK1ALDH1A1
SCHEMBL24039926 0.70 HTR2A (0.51) VCAM1MAPK1ALDH1A1HTR2AHTR2C
SCHEMBL20214612 0.70 HTR2A (0.51) VCAM1MAPK1ALDH1A1HTR2AHTR2C
SCHEMBL14993476 0.70 LRRK2 (0.42) AKR1B1VCAM1TSHRMAPK1ALDH1A1
SCHEMBL31726573 0.69 AHR (0.47) AKR1B1TSHRMAPK1ALDH1A1CYP3A4
SCHEMBL8647059 0.69 AHR (0.47) AKR1B1TSHRMAPK1ALDH1A1CYP3A4
SCHEMBL22271646 0.68 TSHR (0.46) VCAM1TSHRMAPK1ALDH1A1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114716382-B Continuous flow synthesis process of Ensifelvir intermediate of anti-new crown drug 拓信达(启东)医药生物科技有限公司 2023-10-27 CN claimed
CN-114716382-A Continuous flow synthesis process of anti-neocoronal drug Ensittrelvir intermediate 拓信达(启东)医药生物科技有限公司 2022-07-08 CN claimed
CN-114716382-B Continuous flow synthesis process of Ensifelvir intermediate of anti-new crown drug 拓信达(启东)医药生物科技有限公司 2023-10-27 CN disclosed
CN-114716382-A Continuous flow synthesis process of anti-neocoronal drug Ensittrelvir intermediate 拓信达(启东)医药生物科技有限公司 2022-07-08 CN disclosed